Applied Filters
10x Genomics 'overjoyed' to win UPC preliminary injunction
Decision marks first announcement by the UPC of an injunction in open court | Ruling in Munich Local Division forecast to have far-reaching consequences for defendant| Comment from 10x vice president of IP and litigation, Randy Wu.
Harvard and 10x to face anti-competitive claims over genomics patents
Delaware court permits counterclaims from Vizgen and Nanostring in separate suits | Firms say patents-in-suit were covered by ‘open and non-exclusive licenses’.
Vizgen accuses Harvard and 10x of patent licence cover-up
Firm says patents-in-suit were developed using $19 million of public money | Biotech also cites “new evidence” in suit with Harvard and 10x.
Biotech escalates genetic analysis tech dispute
The complaint centres on profiling tech used in genetic analysis | Last year, 10x Genomics accused NanoString of infringing multiple patents related to spatial profiling.
Illumina urges court to overturn DNA patent verdict
Biotech company Illumina has asked a Delaware court to overturn a finding that it willfully infringed two DNA sequencing patents and must pay $334 million in damages.
OptraHealth sues Invitae over genetic testing chatbot
OptraHealth has filed a patent infringement lawsuit against Invitae that centres on the latter’s Gia chatbot that offers genetic testing and advice.
BGI hit with $8m damages bill in patent dispute with Illumina
Illumina has secured an $8 million damages verdict against China-based BGI Genomics, and its US subsidiary, MGI, in a dispute involving gene-sequencing patents.
WIPO unveils course on genetic resources in the life sciences
The World Intellectual Property Office has launched a course on IP and genetic resources in the life sciences.
Fed Circ. affirms Stanford genetics patent rejection
The Federal Circuit has affirmed a Patent Trial and Appeal Board decision denying Stanford University a patent application for calculating parent genes.
Fed Circuit rejects Stanford Uni’s ‘abstract’ genetics patent
Stanford University can’t patent a genetic testing method as it is based on “abstract mathematical calculations”, the US Court of Appeals for the Federal Circuit has ruled.
